Biocon - Global Healthcare Company
About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
  About Us
  Research & Development
  Branded Formulations
  Financial Results
  - Annual Report 2014
  - Investor Presentation
  Facilities Virtual Tour
  - Biocon
  - Syngene
  - Clinigene
  - Biocon Profile
  - CMD Profile
  - Video Gallery

Results of e-Voting
- Annual General Meeting -

for more details, please visit:

Write to:

  Biocon is an emerging global biopharmaceutical enterprise

focused on delivering affordable innovation. It is committed to

reduce therapy costs of chronic diseases like diabetes, cancer

and autoimmune diseases by leveraging India's cost advantage

to deliver affordable healthcare solutions to patients, partners

and healthcare systems across the globe.

Q2 & H1 FY15 Results
Stock Update
  Latest Press Release

Oct 21, 2014
Biocon Q2 FY15 Revenues at
Rs 773 Crore, PAT at Rs 102 Crore...

  Media Coverage

Oct 23, 2014
Business Standard:
We are in process of expansion in Karnataka...

Oct 23, 2014
Financial Express:
Confident that clinical trials climate will improve in next six months...

Oct 23, 2014
The Statesman:
Biocon Q2 net at Rs 102 cr...


Biocon Foundation

Arogya Raksha Yojana

Biocon Malaysia


          Patient Contact

          Patient Contact




Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Clinigene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer | Authorised Users               © 2014, Biocon. All Rights Reserved